section,entity_id,entity_name,entity_name_en,entity_type,category,attribute_path,value
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,name_en,Polycystic Ovary Syndrome (PCOS)
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,description,育龄期女性常见的内分泌代谢疾病，以雄激素过多、排卵障碍和多囊卵巢为特征
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,icd_10,E28.2
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,epidemiology.prevalence,育龄女性5-20%
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,epidemiology.china_prevalence,5.6%(生育年龄女性)
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,epidemiology.adolescent_prevalence,青春期女性3-10%
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,epidemiology.ethnic_variations,各种族均有发病
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnostic_criteria.rotterdam_2003.description,3项中至少2项
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnostic_criteria.rotterdam_2003.criteria,稀发排卵或无排卵; 临床和/或生化雄激素过多; 多囊卵巢形态
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnostic_criteria.nih_1990.description,必须同时具备
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnostic_criteria.nih_1990.criteria,稀发排卵或无排卵; 临床或生化雄激素过多
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnostic_criteria.aes_2006.description,雄激素过多+以下之一
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnostic_criteria.aes_2006.criteria,卵巢功能障碍; 多囊卵巢形态
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,pathophysiology.insulin_resistance.prevalence,50-70%患者
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,pathophysiology.insulin_resistance.mechanism,胰岛素抵抗→高胰岛素血症
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,pathophysiology.insulin_resistance.effects,刺激卵巢雄激素产生; 降低性激素结合球蛋白; 促进脂肪储存
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,pathophysiology.hyperandrogenism.sources,卵巢; 肾上腺
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,pathophysiology.hyperandrogenism.mechanisms,LH刺激卵泡膜细胞; 胰岛素协同作用; 芳香化酶活性降低
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,pathophysiology.hyperandrogenism.consequences,毛囊敏感性增加; 皮脂腺分泌增加; 干扰卵泡发育
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,pathophysiology.ovarian_dysfunction.follicular_arrest,卵泡发育停滞
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,pathophysiology.ovarian_dysfunction.anovulation,排卵障碍
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,pathophysiology.ovarian_dysfunction.altered_steroidogenesis,类固醇生成异常
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.reproductive_features.menstrual_irregularities.oligomenorrhea,月经稀发(>35天)
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.reproductive_features.menstrual_irregularities.amenorrhea,闭经(>90天)
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.reproductive_features.menstrual_irregularities.dysfunctional_bleeding,功能失调性子宫出血
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.reproductive_features.infertility.anovulatory,排卵性不孕
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.reproductive_features.infertility.prevalence,75%不孕症患者
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.reproductive_features.infertility.mechanism,排卵障碍
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.hyperandrogenic_features.hirsutism.definition,Ferriman-Gallwey评分≥6
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.hyperandrogenic_features.hirsutism.distribution,面部、胸部、腹部多毛
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.hyperandrogenic_features.hirsutism.prevalence,60-80%患者
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.hyperandrogenic_features.acne.characteristics,持续性、炎症性痤疮
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.hyperandrogenic_features.acne.distribution,面部、背部、胸部
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.hyperandrogenic_features.acne.severity,中重度
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.hyperandrogenic_features.alopecia.pattern,男性型脱发
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.hyperandrogenic_features.alopecia.location,顶部和颞部
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.hyperandrogenic_features.alopecia.progression,逐渐加重
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.metabolic_features.obesity.prevalence,50-80%患者
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.metabolic_features.obesity.pattern,中心性肥胖
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.metabolic_features.obesity.bmi,BMI≥25kg/m²
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.metabolic_features.insulin_resistance.glucose_intolerance,糖耐量异常
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.metabolic_features.insulin_resistance.diabetes_risk,2型糖尿病风险增加
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.metabolic_features.insulin_resistance.metabolic_syndrome,代谢综合征高发
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.metabolic_features.dyslipidemia.patterns,高甘油三酯; 低HDL-C; 小而密LDL增加
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,laboratory_evaluation.hormonal_assessment.androgens.total_testosterone,>2.5nmol/L
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,laboratory_evaluation.hormonal_assessment.androgens.free_testosterone,计算游离睾酮
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,laboratory_evaluation.hormonal_assessment.androgens.dhea_s,硫酸脱氢表雄酮
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,laboratory_evaluation.hormonal_assessment.androgens.androstenedione,雄烯二酮
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,laboratory_evaluation.hormonal_assessment.reproductive_hormones.lh_fsh_ratio,LH/FSH>2-3
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,laboratory_evaluation.hormonal_assessment.reproductive_hormones.amh,抗苗勒管激素升高
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,laboratory_evaluation.hormonal_assessment.reproductive_hormones.prolactin,排除高催乳素血症
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,laboratory_evaluation.hormonal_assessment.reproductive_hormones.17_ohp,排除先天性肾上腺增生
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,laboratory_evaluation.metabolic_assessment.glucose_metabolism.ogtt,75g口服糖耐量试验
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,laboratory_evaluation.metabolic_assessment.glucose_metabolism.homa_ir,胰岛素抵抗指数
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,laboratory_evaluation.metabolic_assessment.glucose_metabolism.hba1c,糖化血红蛋白
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,laboratory_evaluation.metabolic_assessment.lipid_profile,总胆固醇; 甘油三酯; HDL-C; LDL-C
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,imaging_studies.pelvic_ultrasound.criteria,Rotterdam标准
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,imaging_studies.pelvic_ultrasound.findings.follicle_number,≥12个直径2-9mm卵泡
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,imaging_studies.pelvic_ultrasound.findings.ovarian_volume,>10ml
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,imaging_studies.pelvic_ultrasound.findings.stromal_echogenicity,基质回声增强
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,imaging_studies.pelvic_ultrasound.timing,月经周期任意时间
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modification.weight_management.target,减重5-10%
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modification.weight_management.benefits,改善排卵; 降低雄激素; 改善胰岛素敏感性; 减少心血管风险
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modification.diet.low_glycemic_index,低血糖指数饮食
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modification.diet.caloric_restriction,适度热量限制
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modification.diet.macronutrient_balance,平衡蛋白质、脂肪、碳水
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modification.exercise.aerobic,有氧运动150分钟/周
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modification.exercise.resistance,阻力训练2-3次/周
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modification.exercise.benefits,改善胰岛素敏感性
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.menstrual_regulation.combined_oc.mechanism,抑制LH、增加SHBG
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.menstrual_regulation.combined_oc.benefits,调节月经; 减少雄激素
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.menstrual_regulation.combined_oc.contraindications,血栓风险
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.menstrual_regulation.progestins.medroxyprogesterone,醋酸甲羟孕酮
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.menstrual_regulation.progestins.cyclical_therapy,周期性治疗
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.menstrual_regulation.progestins.duration,10-14天/月
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.hyperandrogenism_treatment.anti_androgens.spironolactone.dose,螺内酯 25-200mg/日
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.hyperandrogenism_treatment.anti_androgens.spironolactone.mechanism,雄激素受体拮抗
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.hyperandrogenism_treatment.anti_androgens.spironolactone.monitoring,血钾、肾功能
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.hyperandrogenism_treatment.anti_androgens.cyproterone_acetate.dose,醋酸环丙孕酮 25-100mg/日
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.hyperandrogenism_treatment.anti_androgens.cyproterone_acetate.combination,与炔雌醇联用
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.hyperandrogenism_treatment.anti_androgens.cyproterone_acetate.contraindications,肝病、血栓
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.hyperandrogenism_treatment.anti_androgens.finasteride.dose,非那雄胺 5mg/日
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.hyperandrogenism_treatment.anti_androgens.finasteride.mechanism,5α-还原酶抑制
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.hyperandrogenism_treatment.anti_androgens.finasteride.indication,男性型脱发
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.hyperandrogenism_treatment.topical_treatments.eflornithine,依氟鸟氨酸乳膏
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.hyperandrogenism_treatment.topical_treatments.indication,面部多毛
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.hyperandrogenism_treatment.topical_treatments.mechanism,鸟氨酸脱羧酶抑制
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.insulin_sensitizers.metformin.dose,二甲双胍 500-2000mg/日
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.insulin_sensitizers.metformin.benefits,改善胰岛素敏感性; 恢复排卵; 减重; 改善代谢指标
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.insulin_sensitizers.metformin.monitoring,肾功能、维生素B12
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.insulin_sensitizers.inositol.myo_inositol,肌醇 2-4g/日
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.insulin_sensitizers.inositol.d_chiro_inositol,D-手性肌醇
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.pharmacological_treatment.insulin_sensitizers.inositol.benefits,改善胰岛素敏感性、排卵
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.fertility_treatment.ovulation_induction.clomiphene_citrate.dose,枸橼酸氯米芬 50-150mg/日
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.fertility_treatment.ovulation_induction.clomiphene_citrate.duration,月经第3-7天，连续5天
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.fertility_treatment.ovulation_induction.clomiphene_citrate.success_rate,排卵率70-80%
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.fertility_treatment.ovulation_induction.letrozole.dose,来曲唑 2.5-7.5mg/日
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.fertility_treatment.ovulation_induction.letrozole.advantages,较少多胎妊娠
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.fertility_treatment.ovulation_induction.letrozole.first_line,PCOS患者首选
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.fertility_treatment.ovulation_induction.gonadotropins.indication,克罗米芬抵抗
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.fertility_treatment.ovulation_induction.gonadotropins.monitoring,超声监测卵泡
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.fertility_treatment.ovulation_induction.gonadotropins.risks,卵巢过度刺激综合征
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.fertility_treatment.assisted_reproduction.ivf,体外受精
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.fertility_treatment.assisted_reproduction.indication,其他治疗失败
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.fertility_treatment.assisted_reproduction.success_rates,与年龄和BMI相关
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_complications.reproductive.infertility,排卵障碍导致不孕
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_complications.reproductive.pregnancy_complications,妊娠期糖尿病; 妊娠期高血压; 早产; 胎儿宫内生长受限
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_complications.reproductive.endometrial_cancer,子宫内膜癌风险增加2-3倍
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_complications.metabolic.type2_diabetes,2型糖尿病风险增加5-10倍
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_complications.metabolic.metabolic_syndrome,代谢综合征患病率35-80%
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_complications.metabolic.cardiovascular_disease,心血管疾病风险增加
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_complications.psychological.depression,抑郁症发病率增加
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_complications.psychological.anxiety,焦虑症状
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_complications.psychological.body_image,身体形象问题
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_complications.psychological.quality_of_life,生活质量下降
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,monitoring.reproductive_health,月经周期规律性; 排卵监测; 子宫内膜厚度; 生育能力评估
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,monitoring.metabolic_monitoring,体重、BMI; 血糖、胰岛素; 血脂谱; 血压
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,monitoring.cancer_screening,子宫内膜病理检查; 宫颈癌筛查; 乳腺癌筛查
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,prognosis.reproductive_outcomes,适当治疗可恢复排卵和生育能力
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,prognosis.metabolic_management,生活方式干预可显著改善代谢指标
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,prognosis.long_term_health,需要终生管理和监测
female_endocrine_entities,FEM_001,多囊卵巢综合征,,reproductive_endocrine_disorder,female_endocrine_disease,prognosis.quality_of_life,综合治疗可明显改善生活质量
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,name_en,Menopausal Syndrome
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,description,围绝经期和绝经后妇女因雌激素缺乏引起的综合征
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,icd_10,N95.1
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,epidemiology.menopause_age,中国女性平均绝经年龄49.5岁
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,epidemiology.perimenopause_duration,围绝经期持续4-8年
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,epidemiology.symptom_prevalence,85%女性有血管舒缩症状
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,epidemiology.severe_symptoms,25%女性症状严重影响生活
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,classification.perimenopause.definition,月经周期不规律开始至绝经后1年
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,classification.perimenopause.early_stage,月经周期长度变化≥7天
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,classification.perimenopause.late_stage,闭经间隔≥60天
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,classification.postmenopause.definition,绝经后阶段
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,classification.postmenopause.early,绝经后1-5年
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,classification.postmenopause.late,绝经后5年以上
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,pathophysiology.ovarian_aging.follicle_depletion,卵泡数量减少
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,pathophysiology.ovarian_aging.hormone_changes,雌激素水平下降; FSH、LH水平升高; 抑制素B降低; AMH降低
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,pathophysiology.estrogen_deficiency_effects.vasomotor,血管舒缩功能异常
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,pathophysiology.estrogen_deficiency_effects.bone_metabolism,骨吸收增加
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,pathophysiology.estrogen_deficiency_effects.cardiovascular,血管内皮功能受损
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,pathophysiology.estrogen_deficiency_effects.urogenital,泌尿生殖道萎缩
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.vasomotor_symptoms.hot_flashes.prevalence,75-85%
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.vasomotor_symptoms.hot_flashes.characteristics,突然发热、出汗
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.vasomotor_symptoms.hot_flashes.duration,平均7.4年
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.vasomotor_symptoms.hot_flashes.frequency,轻度：<1次/天，重度：>10次/天
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.vasomotor_symptoms.night_sweats.prevalence,60-70%
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.vasomotor_symptoms.night_sweats.impact,睡眠质量下降
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.vasomotor_symptoms.night_sweats.consequences,日间疲劳、情绪变化
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.genitourinary_symptoms.vaginal_atrophy.symptoms,阴道干燥; 性交痛; 瘙痒
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.genitourinary_symptoms.vaginal_atrophy.physical_changes,pH升高; 糖原减少; 弹性下降
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.genitourinary_symptoms.urinary_symptoms.frequency,尿频
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.genitourinary_symptoms.urinary_symptoms.urgency,急迫性尿失禁
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.genitourinary_symptoms.urinary_symptoms.infections,反复泌尿系感染
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.psychological_symptoms.mood_changes,情绪波动; 易激惹; 焦虑; 抑郁倾向
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.psychological_symptoms.cognitive_symptoms,记忆力下降; 注意力不集中; 脑雾
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.psychological_symptoms.sleep_disturbances,入睡困难; 睡眠中断; 早醒
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.physical_changes.body_composition,腹部脂肪增加; 肌肉量减少; 体重增加
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,clinical_manifestations.physical_changes.skin_hair_changes,皮肤干燥; 弹性减退; 毛发稀疏
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnosis.clinical_diagnosis.age_criteria,45岁以上女性
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnosis.clinical_diagnosis.menstrual_changes,月经模式改变
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnosis.clinical_diagnosis.symptom_constellation,典型症状组合
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnosis.laboratory_tests.fsh.perimenopause,>25IU/L
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnosis.laboratory_tests.fsh.postmenopause,>40IU/L
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnosis.laboratory_tests.fsh.variability,围绝经期波动大
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnosis.laboratory_tests.estradiol.levels,<30pg/mL
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnosis.laboratory_tests.estradiol.variability,围绝经期不稳定
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnosis.laboratory_tests.amh.low_levels,<1.0ng/mL
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnosis.laboratory_tests.amh.predictor,绝经时间预测
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,diagnosis.differential_diagnosis,甲状腺疾病; 抑郁症; 焦虑症; 其他内分泌疾病
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.systemic_ht.indications,中重度血管舒缩症状; 泌尿生殖道症状; 骨质疏松预防
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.systemic_ht.contraindications,乳腺癌史; 子宫内膜癌史; 血栓栓塞史; 未诊断的阴道出血; 活动性肝病
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.systemic_ht.regimens.continuous_combined.indication,绝经后妇女
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.systemic_ht.regimens.continuous_combined.composition,雌激素+孕激素每日
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.systemic_ht.regimens.continuous_combined.bleeding,通常无撤退性出血
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.systemic_ht.regimens.cyclical.indication,围绝经期妇女
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.systemic_ht.regimens.cyclical.composition,雌激素连续+孕激素周期性
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.systemic_ht.regimens.cyclical.bleeding,有规律撤退性出血
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.systemic_ht.preparations.oral.estradiol,雌二醇 1-2mg/日
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.systemic_ht.preparations.oral.conjugated_estrogens,结合雌激素 0.625mg/日
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.systemic_ht.preparations.oral.progestins,地屈孕酮; 微粒化黄体酮
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.systemic_ht.preparations.transdermal.patches,雌激素贴剂
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.systemic_ht.preparations.transdermal.gels,雌激素凝胶
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.systemic_ht.preparations.transdermal.advantages,避免首过效应
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.local_therapy.vaginal_estrogen.preparations,雌激素栓剂; 乳膏; 阴道环
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.local_therapy.vaginal_estrogen.indications,泌尿生殖道症状
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.hormone_therapy.local_therapy.vaginal_estrogen.safety,全身吸收minimal
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.non_hormonal_treatments.vasomotor_symptoms.ssri_snri.paroxetine,帕罗西汀 7.5mg/日
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.non_hormonal_treatments.vasomotor_symptoms.ssri_snri.venlafaxine,文拉法辛 75mg/日
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.non_hormonal_treatments.vasomotor_symptoms.ssri_snri.efficacy,减少潮热50-60%
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.non_hormonal_treatments.vasomotor_symptoms.gabapentin.dose,加巴喷丁 300-900mg/日
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.non_hormonal_treatments.vasomotor_symptoms.gabapentin.indication,夜间潮热
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.non_hormonal_treatments.vasomotor_symptoms.gabapentin.side_effects,嗜睡、头晕
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.non_hormonal_treatments.vasomotor_symptoms.clonidine.dose,可乐定 0.1mg bid
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.non_hormonal_treatments.vasomotor_symptoms.clonidine.mechanism,α2受体激动剂
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.non_hormonal_treatments.vasomotor_symptoms.clonidine.side_effects,低血压、口干
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.non_hormonal_treatments.complementary_therapies.cognitive_behavioral_therapy,认知行为疗法
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.non_hormonal_treatments.complementary_therapies.mindfulness,正念减压
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.non_hormonal_treatments.complementary_therapies.acupuncture,针灸治疗
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.non_hormonal_treatments.complementary_therapies.yoga,瑜伽练习
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modifications.diet.calcium,1200mg/日
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modifications.diet.vitamin_d,800-1000IU/日
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modifications.diet.phytoestrogens,大豆异黄酮
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modifications.diet.avoid_triggers,避免辛辣食物、咖啡因
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modifications.exercise.aerobic,有氧运动150分钟/周
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modifications.exercise.resistance,阻力训练
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modifications.exercise.weight_bearing,负重运动
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modifications.exercise.pelvic_floor,盆底肌训练
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,treatment.lifestyle_modifications.stress_management,规律作息; 充足睡眠; 压力管理; 社交支持
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,monitoring.hormone_therapy_monitoring.clinical_response,症状改善评估
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,monitoring.hormone_therapy_monitoring.side_effects,乳房胀痛; 阴道出血; 血栓风险; 胆囊疾病
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,monitoring.hormone_therapy_monitoring.annual_assessments,乳腺检查; 妇科检查; 血压监测; 血脂检查
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,monitoring.long_term_health,骨密度检测; 心血管风险评估; 癌症筛查; 认知功能评估
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_health_consequences.bone_health.bone_loss,绝经后5年内骨量丢失20%
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_health_consequences.bone_health.fracture_risk,髋部骨折风险显著增加
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_health_consequences.bone_health.prevention,钙、维生素D、运动、HT
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_health_consequences.cardiovascular_health.risk_increase,绝经后心血管疾病风险增加
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_health_consequences.cardiovascular_health.mechanisms,血脂谱恶化; 血管内皮功能受损; 胰岛素抵抗增加
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_health_consequences.cardiovascular_health.prevention,生活方式干预、风险因素控制
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_health_consequences.cognitive_health.dementia_risk,痴呆症风险可能增加
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_health_consequences.cognitive_health.memory_changes,记忆力和认知功能变化
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,long_term_health_consequences.cognitive_health.protection,教育、社交活动、智力刺激
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,prognosis.symptom_duration,血管舒缩症状平均持续7-10年
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,prognosis.treatment_response,激素治疗有效率80-90%
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,prognosis.quality_of_life,适当治疗可显著改善生活质量
female_endocrine_entities,FEM_002,绝经期综合征,,reproductive_endocrine_disorder,female_endocrine_disease,prognosis.long_term_outcomes,综合管理可预防长期健康风险
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,name_en,Gestational Diabetes Mellitus (GDM)
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,description,妊娠期首次发现或发病的糖代谢异常
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,icd_10,O24.4
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,epidemiology.global_prevalence,1-14%(因诊断标准而异)
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,epidemiology.china_prevalence,14.8%(2019年数据)
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,epidemiology.increasing_trend,患病率逐年上升
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,epidemiology.risk_factors_prevalence,高龄妊娠、肥胖增加
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,pathophysiology.pregnancy_insulin_resistance.mechanism,胎盘激素导致胰岛素抵抗
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,pathophysiology.pregnancy_insulin_resistance.hormones,人胎盘生长激素; 皮质醇; 胎盘催乳素; 孕激素
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,pathophysiology.pregnancy_insulin_resistance.timeline,妊娠20周后明显
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,pathophysiology.beta_cell_dysfunction.inadequate_compensation,β细胞代偿不足
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,pathophysiology.beta_cell_dysfunction.genetic_predisposition,遗传易感性
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,pathophysiology.beta_cell_dysfunction.environmental_factors,肥胖、年龄等
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,risk_factors.maternal_factors.age,≥35岁
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,risk_factors.maternal_factors.obesity,孕前BMI≥25kg/m²
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,risk_factors.maternal_factors.family_history,糖尿病家族史
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,risk_factors.maternal_factors.ethnicity,高危种族
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,risk_factors.obstetric_history.previous_gdm,既往GDM史
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,risk_factors.obstetric_history.macrosomia,既往巨大儿分娩史
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,risk_factors.obstetric_history.stillbirth,死胎史
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,risk_factors.obstetric_history.polyhydramnios,羊水过多史
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,risk_factors.medical_history.pcos,多囊卵巢综合征
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,risk_factors.medical_history.hypertension,高血压
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,risk_factors.medical_history.previous_igt,既往糖耐量异常
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,diagnosis.screening_timing.universal_screening,24-28孕周
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,diagnosis.screening_timing.early_screening,高危因素者孕早期
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,diagnosis.screening_timing.method,75g OGTT
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,diagnosis.diagnostic_criteria.iadpsg_2010.fasting,≥5.1mmol/L
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,diagnosis.diagnostic_criteria.iadpsg_2010.1h_post_load,≥10.0mmol/L
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,diagnosis.diagnostic_criteria.iadpsg_2010.2h_post_load,≥8.5mmol/L
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,diagnosis.diagnostic_criteria.iadpsg_2010.diagnosis,任一时间点异常即诊断
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,diagnosis.diagnostic_criteria.who_2013,采用IADPSG标准
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,diagnosis.diagnostic_criteria.china_2014,基本采用IADPSG标准
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,diagnosis.differential_diagnosis.overt_diabetes.criteria,空腹血糖≥7.0mmol/L; 随机血糖≥11.1mmol/L; HbA1c≥6.5%
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,diagnosis.differential_diagnosis.overt_diabetes.timing,妊娠期任何时间
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,clinical_manifestations.maternal_symptoms.often_asymptomatic,多数无症状
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,clinical_manifestations.maternal_symptoms.classic_symptoms,多饮、多尿; 疲劳; 反复感染
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,clinical_manifestations.fetal_complications.macrosomia.definition,出生体重≥4000g
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,clinical_manifestations.fetal_complications.macrosomia.mechanism,胎儿高胰岛素血症
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,clinical_manifestations.fetal_complications.macrosomia.complications,肩难产; 产伤
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,clinical_manifestations.fetal_complications.neonatal_complications,新生儿低血糖; 呼吸窘迫综合征; 高胆红素血症; 低钙血症; 红细胞增多症
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.nutritional_therapy.caloric_intake.normal_weight,30kcal/kg/日
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.nutritional_therapy.caloric_intake.overweight,25kcal/kg/日
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.nutritional_therapy.caloric_intake.obese,12-14kcal/kg/日
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.nutritional_therapy.macronutrient_distribution.carbohydrate,40-50%
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.nutritional_therapy.macronutrient_distribution.protein,20-25%
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.nutritional_therapy.macronutrient_distribution.fat,25-30%
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.nutritional_therapy.meal_planning.frequency,少量多餐
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.nutritional_therapy.meal_planning.timing,规律进餐时间
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.nutritional_therapy.meal_planning.complex_carbs,复合碳水化合物为主
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.exercise_therapy.type,低强度有氧运动
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.exercise_therapy.duration,30分钟/次，每周5次
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.exercise_therapy.contraindications,前置胎盘; 早产史; 妊娠期高血压
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.glucose_monitoring.frequency,每日4-7次
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.glucose_monitoring.timing,空腹; 三餐后2小时; 必要时餐后1小时
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.glucose_monitoring.targets.fasting,<5.3mmol/L
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.glucose_monitoring.targets.1h_postprandial,<7.8mmol/L
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.glucose_monitoring.targets.2h_postprandial,<6.7mmol/L
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.insulin_therapy.indications,饮食运动治疗2周后血糖不达标; 空腹血糖≥5.3mmol/L; 餐后血糖反复超标
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.insulin_therapy.insulin_types.rapid_acting,门冬胰岛素、赖脯胰岛素
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.insulin_therapy.insulin_types.intermediate,NPH胰岛素
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.insulin_therapy.insulin_types.long_acting,地特米胰岛素
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.insulin_therapy.regimens.basal_bolus,基础-餐时胰岛素
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.insulin_therapy.regimens.bid_nph,NPH胰岛素每日两次
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.insulin_therapy.regimens.adjustment,根据血糖调整剂量
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.oral_agents.metformin.safety,FDA妊娠期B类
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.oral_agents.metformin.indications,部分国家指南推荐
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.oral_agents.metformin.monitoring,胎儿生长发育
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.oral_agents.glyburide.use,部分地区使用
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,management.oral_agents.glyburide.concerns,胎盘通透性
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,monitoring.maternal_monitoring.glucose_control,血糖日记记录
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,monitoring.maternal_monitoring.weight_gain,孕期体重管理
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,monitoring.maternal_monitoring.blood_pressure,血压监测
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,monitoring.maternal_monitoring.ketones,尿酮体检查
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,monitoring.fetal_monitoring.growth_assessment.ultrasound,每4周超声检查
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,monitoring.fetal_monitoring.growth_assessment.biometry,胎儿生物测量
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,monitoring.fetal_monitoring.growth_assessment.amniotic_fluid,羊水量评估
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,monitoring.fetal_monitoring.fetal_wellbeing.nst,胎心监护
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,monitoring.fetal_monitoring.fetal_wellbeing.bpp,生物物理评分
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,monitoring.fetal_monitoring.fetal_wellbeing.timing,32-34周开始
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,delivery_management.timing.well_controlled,39-40周
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,delivery_management.timing.poor_control,考虑提前终止妊娠
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,delivery_management.timing.macrosomia,38-39周
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,delivery_management.mode_of_delivery.vaginal_delivery,首选自然分娩
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,delivery_management.mode_of_delivery.cesarean_indications,估计胎重≥4500g; 既往肩难产史; 产科指征
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,delivery_management.intrapartum_management.glucose_monitoring,每1-2小时监测血糖
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,delivery_management.intrapartum_management.insulin_adjustment,根据血糖调整胰岛素
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,delivery_management.intrapartum_management.target,血糖4.0-7.0mmol/L
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,postpartum_care.immediate_postpartum.insulin_discontinuation,胰岛素立即停用
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,postpartum_care.immediate_postpartum.glucose_monitoring,监测血糖变化
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,postpartum_care.immediate_postpartum.breastfeeding,鼓励母乳喂养
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,postpartum_care.follow_up_screening.timing,产后6-12周
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,postpartum_care.follow_up_screening.method,75g OGTT
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,postpartum_care.follow_up_screening.interpretation,评估糖代谢状态
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,postpartum_care.long_term_follow_up.annual_screening,每年糖尿病筛查
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,postpartum_care.long_term_follow_up.lifestyle_counseling,生活方式指导
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,postpartum_care.long_term_follow_up.preconception_counseling,再次妊娠前咨询
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,complications.maternal_complications.pregnancy,妊娠期高血压; 子痫前期; 羊水过多; 感染风险增加
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,complications.maternal_complications.delivery,剖宫产率增加; 产后出血; 产道损伤
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,complications.fetal_neonatal_complications.immediate,新生儿低血糖; 呼吸窘迫; 高胆红素血症; 低钙血症
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,complications.fetal_neonatal_complications.long_term,儿童期肥胖; 青春期糖尿病风险; 代谢综合征
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,long_term_outcomes.maternal_outcomes.diabetes_risk,50-70%发展为2型糖尿病
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,long_term_outcomes.maternal_outcomes.cardiovascular_risk,心血管疾病风险增加
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,long_term_outcomes.maternal_outcomes.recurrence_risk,再次妊娠复发率30-84%
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,long_term_outcomes.offspring_outcomes.obesity_risk,儿童肥胖风险增加
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,long_term_outcomes.offspring_outcomes.diabetes_risk,青春期糖尿病风险增加
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,long_term_outcomes.offspring_outcomes.metabolic_programming,代谢编程效应
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,prevention.primary_prevention.preconception,体重管理; 健康饮食; 规律运动; 叶酸补充
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,prevention.secondary_prevention.lifestyle_interventions,饮食指导; 运动计划; 体重控制; 定期随访
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,prognosis.immediate_outcomes,良好的血糖控制可改善母儿结局
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,prognosis.long_term_health,需要终生糖尿病风险管理
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,prognosis.quality_of_life,适当管理下可维持正常生活
female_endocrine_entities,FEM_003,妊娠期糖尿病,,pregnancy_related_disorder,female_endocrine_disease,prognosis.family_planning,可安全进行再次妊娠
